Journey Medical Corporation (DERM)

USD 7.03

(2.18%)

Total Assets Summary of Journey Medical Corporation

  • Journey Medical Corporation's latest annual total assets in 2023 was 76.84 Million USD , down -26.92% from previous year.
  • Journey Medical Corporation's latest quarterly total assets in 2024 Q1 was 66.57 Million USD , down -13.37% from previous quarter.
  • Journey Medical Corporation reported annual total assets of 105.16 Million USD in 2022, up 8.1% from previous year.
  • Journey Medical Corporation reported annual total assets of 97.28 Million USD in 2021, up 87.42% from previous year.
  • Journey Medical Corporation reported quarterly total assets of 65.18 Million USD for 2024 Q2, down -2.08% from previous quarter.
  • Journey Medical Corporation reported quarterly total assets of 95.85 Million USD for 2023 Q1, down -8.85% from previous quarter.

Annual Total Assets Chart of Journey Medical Corporation (2023 - 2014)

Historical Annual Total Assets of Journey Medical Corporation (2023 - 2014)

Year Total Assets Total Assets Growth
2023 76.84 Million USD -26.92%
2022 105.16 Million USD 8.1%
2021 97.28 Million USD 87.42%
2020 51.9 Million USD 53.3%
2019 33.85 Million USD -90.17%
2018 344.32 Million USD -38.6%
2017 560.79 Million USD 79.4%
2016 312.6 Million USD 40.85%
2015 221.93 Million USD 24.53%
2014 178.22 Million USD 0.0%

Peer Total Assets Comparison of Journey Medical Corporation

Name Total Assets Total Assets Difference
ANI Pharmaceuticals, Inc. 904.42 Million USD 91.503%
Aquestive Therapeutics, Inc. 57.41 Million USD -33.841%
Collegium Pharmaceutical, Inc. 1.14 Billion USD 93.278%
Cosmos Health Inc. 66.29 Million USD -15.919%
Cyclo Therapeutics, Inc. 13.24 Million USD -480.1%
Esperion Therapeutics, Inc. 205.79 Million USD 62.658%
Cronos Group Inc. 1.13 Billion USD 93.225%
Incannex Healthcare Limited 17.04 Million USD -350.807%
Kala Pharmaceuticals, Inc. 55.94 Million USD -37.355%
Lifecore Biomedical, Inc. 273.7 Million USD 71.922%
Regencell Bioscience Holdings Limited 8.43 Million USD -810.726%
Sunshine Biopharma, Inc. 27.34 Million USD -181.015%
Sunshine Biopharma, Inc. 27.34 Million USD -181.015%
SCYNEXIS, Inc. 128.41 Million USD 40.154%
Safety Shot Inc 12.7 Million USD -504.673%
Theratechnologies Inc. 77.76 Million USD 1.183%
Alpha Teknova, Inc. 128.58 Million USD 40.236%
Universe Pharmaceuticals INC 53.28 Million USD -44.217%
Pacira BioSciences, Inc. 1.57 Billion USD 95.119%
Sonoma Pharmaceuticals, Inc. 14.89 Million USD -416.008%
Dynavax Technologies Corporation 997.09 Million USD 92.293%
Ironwood Pharmaceuticals, Inc. 471.07 Million USD 83.686%
Radius Health, Inc. 1.71 Billion USD 95.521%
China SXT Pharmaceuticals, Inc. 23.12 Million USD -232.29%
Alvotech 950.09 Million USD 91.911%
Intra-Cellular Therapies, Inc. 728.29 Million USD 89.448%
SIGA Technologies, Inc. 254.83 Million USD 69.844%
Shineco, Inc. 84.17 Million USD 8.708%
Silver Spike Investment Corp. 88.57 Million USD 13.24%
Petros Pharmaceuticals, Inc. 33.79 Million USD -127.392%
Embecta Corp. 1.21 Billion USD 93.672%
Harrow Health, Inc. 311.75 Million USD 75.35%
Procaps Group, S.A. 460.18 Million USD 83.3%
Biofrontera Inc. 27.93 Million USD -175.129%
DURECT Corporation 45.18 Million USD -70.061%
PainReform Ltd. 9.93 Million USD -673.907%
Supernus Pharmaceuticals, Inc. 1.4 Billion USD 94.546%
OptiNose, Inc. 107.72 Million USD 28.665%
RedHill Biopharma Ltd. 23.04 Million USD -233.443%
Organogenesis Holdings Inc. 460.02 Million USD 83.295%
Cumberland Pharmaceuticals Inc. 81.77 Million USD 6.025%
ProPhase Labs, Inc. 91.92 Million USD 16.402%
Phibro Animal Health Corporation 982.18 Million USD 92.176%
Procaps Group S.A. 460.18 Million USD 83.3%
TherapeuticsMD, Inc. 43.3 Million USD -77.443%
Viatris Inc. 47.68 Billion USD 99.839%
Rockwell Medical, Inc. 52.17 Million USD -47.296%
Aytu BioPharma, Inc. 118.09 Million USD 34.926%
Tilray Brands, Inc. 4.33 Billion USD 98.227%
PetIQ, Inc. 868.22 Million USD 91.149%
Talphera, Inc. 20.39 Million USD -276.803%
Neurocrine Biosciences, Inc. 3.25 Billion USD 97.636%
Alimera Sciences, Inc. 153.52 Million USD 49.943%
Assertio Holdings, Inc. 286.41 Million USD 73.169%
Shuttle Pharmaceuticals Holdings, Inc. 5.95 Million USD -1191.203%
Avadel Pharmaceuticals plc 261.12 Million USD 70.57%
Hempacco Co., Inc. 18.04 Million USD -325.92%
Alvotech 950.09 Million USD 91.911%
Lantheus Holdings, Inc. 1.65 Billion USD 95.346%
Kamada Ltd. 351.96 Million USD 78.166%
Currenc Group, Inc. 141.49 Million USD 45.686%
Indivior PLC 1.95 Billion USD 96.062%
Evoke Pharma, Inc. 7.06 Million USD -987.197%
Flora Growth Corp. 23.62 Million USD -225.273%
Cyclo Therapeutics, Inc. 13.24 Million USD -480.1%
Evolus, Inc. 188.99 Million USD 59.339%
HUTCHMED (China) Limited 1.27 Billion USD 93.995%
Amphastar Pharmaceuticals, Inc. 1.51 Billion USD 94.92%
Akanda Corp. 8.83 Million USD -769.333%